A novel mechanism of natural vitamin E tocotrienol activity: involvement of ERbeta signal transduction.
about
Fat-Soluble Vitamins: Clinical Indications and Current Challenges for Chromatographic MeasurementSupplementation with α-lipoic acid, CoQ10, and vitamin E augments running performance and mitochondrial function in female miceSynergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A ReviewΔ(9)-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor β (ERβ)Gonadotropin-positive pituitary tumors accompanied by ovarian tumors in aging female ERbeta-/- mice.Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.Pharmacological potential of tocotrienols: a review.Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trialMetabolism of tocotrienols in animals and synergistic inhibitory actions of tocotrienols with atorvastatin in cancer cellsTocotrienols and breast cancer: the evidence to date.Tocotrienols fight cancer by targeting multiple cell signaling pathways.Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E.Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherolVitamin E as an Antiosteoporotic Agent via Receptor Activator of Nuclear Factor Kappa-B Ligand Signaling Disruption: Current Evidence and Other Potential Research AreasMolecular and Biochemical Analysis of the Estrogenic and Proliferative Properties of Vitamin E Compounds.New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells.Tocotrienols induce endoplasmic reticulum stress and apoptosis in cervical cancer cells.Delta-tocotrienol induces apoptotic cell death via depletion of intracellular squalene in ED40515 cells.Tocotrienol and Its Role in Chronic Diseases.Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer.Tocotrienols: A Family of Molecules with Specific Biological Activities.
P2860
Q26750862-419A71A0-D099-4F3A-9538-3971D5DA9360Q27329547-AE90B11B-ECE4-4DF0-B900-F16C89680E64Q28074119-D2A03C9D-5A9A-4175-95AA-512F7C76CA7CQ33601161-5949431B-57AA-44A0-913F-799F8B1273FBQ33778664-4E729285-12BC-4140-9956-E4E4D11815AEQ34209443-5B8114DC-5EDB-402C-93DB-6E29D0E48971Q34450166-FDA07618-8827-4EC8-BF1A-8E180B1F69E3Q34989124-5FD22FE0-4E13-4934-A55A-344F2828ACBDQ35648909-896AED82-9B72-4CB8-9AC8-1372EAC87662Q35648930-B76A4820-CC66-4330-8BA6-7EDD76B55397Q35648940-C25A63B7-1387-48E0-9C12-09468D310769Q35648953-DBE6AD22-0378-4319-A255-744487781159Q35671133-0D619FA7-4CDB-4A55-8919-289944B7905DQ36165613-2963011E-592C-43C1-A0D2-66814763C749Q36427475-EB323CB9-3011-42D0-A3E1-18BFF10D3133Q36603335-73B7C2BB-CFBF-442D-8436-06ABA8265900Q37529613-BBE85D1A-6CBF-4AD5-B730-5003062952FDQ38956158-30932633-B2C5-4B68-9724-809523212E09Q38965196-B2488A4B-33E7-4551-9942-CF6A85A8750DQ39376844-54D21FAE-9A16-4870-8CD6-C96B6E301CE6Q47116951-D2035D5F-C50E-415C-B796-97B4F15E5F43
P2860
A novel mechanism of natural vitamin E tocotrienol activity: involvement of ERbeta signal transduction.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A novel mechanism of natural v ...... of ERbeta signal transduction.
@en
A novel mechanism of natural v ...... of ERbeta signal transduction.
@nl
type
label
A novel mechanism of natural v ...... of ERbeta signal transduction.
@en
A novel mechanism of natural v ...... of ERbeta signal transduction.
@nl
prefLabel
A novel mechanism of natural v ...... of ERbeta signal transduction.
@en
A novel mechanism of natural v ...... of ERbeta signal transduction.
@nl
P2093
P2860
P50
P1476
A novel mechanism of natural v ...... of ERbeta signal transduction.
@en
P2093
Fabio Virgili
Kalanithi Nesaretnam
Maria Marino
Raffaella Comitato
P2860
P304
P356
10.1152/AJPENDO.00187.2009
P577
2009-06-02T00:00:00Z